Long-term effects on the brain after covid-19 | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Start & end year
N/A
Known Financial Commitments (USD)
$590,720
Funder
Swedish Research Council
Principal Investigator
Magnus Gisslen
Research Location
Sweden
Lead Research Institution
University of Gothenburg
Research Priority Alignment
N/A

Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

12 Publications linked via Europe PMC

Last Updated:6 days ago

View all publications at Europe PMC

Effect of 6-week tadalafil treatment on blood-based biomarkers of neurodegeneration: A post-hoc analysis of a randomized controlled trial.

Cognitive Trajectories from Preclinical Alzheimer's Disease to Dementia.

Sociodemographic factors influencing SARS-CoV-2 vaccination uptake in people with and without HIV: Insights from a Swedish Nationwide cohort.

The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients.

Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.

Regional differences in COVID-19 vaccine uptake and their determinants among Swedish older adults.

Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in Sweden.

COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.

Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study.